Effect of Dual-wave Insulin Bolus on Postprandial Glycaemia

Status Completed

Clinical Trial Summary

A study was conducted in adolescents with type 1 diabetes (T1D) examining the effect of different bolus types on 6-h postprandial glucose levels after the consumption of 3 standard meals with varying composition. Participants were asked to consume 10 different combinations of meal and bolus type.

Clinical Trial Description

The nutritional recommendations of children and adolescents with T1D should be similar to those of healthy people in order to achieve the desirable growth. Not only the carbohydrates' intake is underlined according to special guidelines by Canadian diabetes association, American diabetes association and International Society for Paediatric and Adolescent Diabetes but also proteins and fats are suggested to be taken into consideration in the management of T1D. In order to reach the desirable euglycemic control, children and adolescents can use multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII). By using the CSII the insulin can be administrated in three different patterns; as a normal bolus, as a dual wave bolus and as a square wave bolus. Dual wave insulin bolus (D/WB) is suggested as the most suitable option based on the effects that is having after meals with different content of carbohydrates, fats and proteins. The aim of this study was to evaluate the impact of different types of D/WB on PPG after 3 given meals, in adolescents with T1D on CSII. In order to achieve that, 3 different meals were designed and combined with alternative types of boluses, D/WB and square wave insulin bolus (S/WB). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03179280
Study type	Interventional
Source	Aristotle University Of Thessaloniki
Contact
Status	Completed
Phase	N/A
Start date	March 2011
Completion date	May 2011

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05536232` - Residual Insulin Secretion in Patients With Type 1 Diabetes Under a Low Carbohydrate Diet or a Ketogenic Diet	N/A
Completed	`NCT04255381` - Yale-Harvard Hotel-based Closed-Loop Studies in Children (HY-GRAID)	N/A
Completed	`NCT04625595` - Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes	Phase 1
Active, not recruiting	`NCT06177691` - Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study
Completed	`NCT04002557` - Optimising Consultation Summaries to Promote Good Health
Completed	`NCT05876273` - Neural-net Artificial Pancreas (NAP)	N/A
Withdrawn	`NCT03236558` - The Role of the Thymus in Type I Diabetes.	N/A
Completed	`NCT06253351` - Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age With Type 1 Diabetes
Completed	`NCT01357603` - Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM	Phase 1
Completed	`NCT04233034` - Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes	Phase 3
Not yet recruiting	`NCT06408207` - CGM Academy for Youth With Type 1 Diabetes	N/A
Recruiting	`NCT06408558` - Safe Use of New Technologies in Diabetes in Flight	N/A
Active, not recruiting	`NCT03782636` - Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)	Phase 2
Completed	`NCT04520971` - Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes	N/A
Recruiting	`NCT05766657` - Evaluation of an Anti-inflammatory Diet in Autoimmune and Metabolic Diseases	N/A
Completed	`NCT01838083` - Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes Mellitus	Phase 1